Alamanos Yannis, Tsifetaki Niki, Voulgari Paraskevi V, Siozos Christos, Tsamandouraki Kiriaki, Alexiou George A, Drosos Alexandros A
Medical School, University of Ioannina, Greece.
Semin Arthritis Rheum. 2005 Apr;34(5):714-20. doi: 10.1016/j.semarthrit.2004.09.001.
To investigate the incidence and prevalence, as well as the mortality and survival rates, of systemic sclerosis (SSc) in a defined area of northwest Greece with a population of about 500,000 inhabitants.
Cases have been recorded from the following sources: (1) inpatients and outpatients referred to the Rheumatology Clinics of the Ioannina University Hospital and the Ioannina General Hospital; (2) patients referred to the private rheumatologists practicing in the study area. All patients recorded between 1/1/1981 and 31/12/2002, resident in the study area, were included in the study. Diagnosis was based on the American College of Rheumatology classification criteria for SSc. Incidence and prevalence rates were calculated as number of cases per 10(5) inhabitants. Population data were based on the National Census of 1981, 1991, and 2001.
The age-adjusted prevalence of SSc was 15.40 cases/10(5) inhabitants on 31/12/2002. A total of 109 new cases were diagnosed during the study period, giving a mean annual age-adjusted incidence rate of 1.10 cases/10 5 inhabitants. There were 98 women and 11 men, giving a ratio of 8.9/1. Limited SSc was diagnosed in 75% and diffuse in 25% of the patients. Esophageal involvement was found in 59%, lung involvement in 56%, and renal disease in 5%. Thirty-six deaths were recorded during the study period in this incidence cohort. The 5-year survival rate was 83% and the 10-year survival rate was 70%.
The incidence and prevalence of SSc in northwest Greece were found to be lower than those of the USA and Australia, and higher than those of northern European countries and Japan. The survival rates were similar to those reported by other studies.
调查希腊西北部一个约有50万居民的特定地区系统性硬化症(SSc)的发病率、患病率以及死亡率和生存率。
病例记录来自以下来源:(1)约阿尼纳大学医院和约阿尼纳综合医院风湿病诊所的住院患者和门诊患者;(2)在研究区域执业的私人风湿病医生转诊的患者。所有于1981年1月1日至2002年12月31日期间记录在案、居住在研究区域的患者均纳入本研究。诊断依据美国风湿病学会SSc分类标准。发病率和患病率按每10⁵居民中的病例数计算。人口数据基于1981年、1991年和2001年的全国人口普查。
2002年12月31日,SSc的年龄调整患病率为每10⁵居民中有15.40例。研究期间共诊断出109例新病例,年龄调整后的年平均发病率为每10⁵居民中有1.10例。其中女性98例,男性11例,比例为8.9/1。75%的患者被诊断为局限性SSc,25%为弥漫性SSc。59%的患者有食管受累,56%有肺部受累,5%有肾脏疾病。在该发病队列的研究期间记录了36例死亡。5年生存率为83%,10年生存率为70%。
希腊西北部SSc的发病率和患病率低于美国和澳大利亚,高于北欧国家和日本。生存率与其他研究报告的相似。